PMX produces a wide range of EPA registered MicroGuard antimicrobial copper alloys in a variety of finishes and textures. Download the MicroGuard Antimicrobial Copper Alloy Guide for more technical information. Safe to use, MicroGuard materials have been approved for use on touch surfaces in healthcare facilities, schools, hotels, airports, malls and other public and commercial buildings.

The CDC estimates that 80% of infections are transmitted by touch. While most furnishings for healthcare facilities and other public spaces are developed for easy cleaning, tests have shown that bacteria* still survive for many days on most of these materials even after cleaning. Research shows that even the best cleaning and disinfection efforts do not always reduce the microbial burden on these touch surfaces to benign levels. Following terminal cleaning, one study showed that 74% of hospital room surfaces still had MRSA.

Evidence based practices show that by reducing microbial burden* on frequently touched surfaces, you can reduce the transmission of bacteria* that cause hospital acquired infections.

MicroGuard reduces the buildup and growth of deadly bacteria* on environmental surfaces. On MicroGuard surfaces, 99.9% of bacteria* will die within two hours as long as the surfaces are not painted, waxed, varnished or coated in any way. MicroGuard continuously reduces microbial burden* in between routine cleaning.

For architects and designers that want to duplicate the look of stainless steel, MicroGuard antimicrobial copper alloys have been developed to match the look of stainless steel with the added benefit of killing infectious bacteria* including MRSA and VRE. Stronger than aluminum alloys, MicroGuard can replace stainless steel in many applications. MicroGuard touch surfaces have been approved for use on over 100 different products.

*Testing demonstrates effective antibacterial activity against Staphylococcus aureus, Enterobacter aerogenes, Methicillin-resistant Staphylococcus aureus (MRSA), Escherichia coli O157:H7, Pseudomonas aeruginosa, and Vancomycin-resistant Enterococcus faecalis (VRE).